Fate Therapeutics Inc (FATE)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$1.13

Buy

$1.15

arrow-up$0.04 (+3.60%)

Prices updated at 13 Dec 2025, 00:34 EST

Prices minimum 15 mins delay

Prices in USD

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$1.17 - $1.09
	$2.07 - $0.66
	-
	132.66m
	-
	-
	1,407,674
	0.57
	2,084,409.76
	3.42
	113.93m
	US31189P1021
	-1.33
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.